As of 2025-07-05, the Relative Valuation of Abivax SA (ABVX.PA) is (20.35) EUR. This relative valuation is based on P/E multiples. With the latest stock price at 7.03 EUR, the upside of Abivax SA based on Relative Valuation is -389.5%.
The range of the Relative Valuation is (18.50) - (15.95) EUR.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 3.8x - 5.7x | 4.8x |
| Forward P/E multiples | 6.7x - 13.1x | 9.9x |
| Fair Price | (18.50) - (15.95) | (20.35) |
| Upside | -363.2% - -326.8% | -389.5% |
| Date | P/E |
| 2025-07-03 | -2.41 |
| 2025-07-02 | -2.47 |
| 2025-07-01 | -2.38 |
| 2025-06-30 | -2.39 |
| 2025-06-27 | -2.25 |
| 2025-06-26 | -2.17 |
| 2025-06-25 | -2.09 |
| 2025-06-24 | -2.02 |
| 2025-06-23 | -1.86 |
| 2025-06-20 | -1.89 |
| 2025-06-19 | -1.91 |
| 2025-06-18 | -1.90 |
| 2025-06-17 | -2.03 |
| 2025-06-16 | -2.05 |
| 2025-06-13 | -2.08 |
| 2025-06-12 | -2.25 |
| 2025-06-11 | -2.39 |
| 2025-06-10 | -2.40 |
| 2025-06-09 | -2.44 |
| 2025-06-06 | -2.65 |
| 2025-06-05 | -2.52 |
| 2025-06-04 | -2.56 |
| 2025-06-03 | -2.36 |
| 2025-06-02 | -1.97 |
| 2025-05-30 | -1.90 |
| 2025-05-29 | -1.88 |
| 2025-05-28 | -1.86 |
| 2025-05-27 | -1.86 |
| 2025-05-26 | -1.93 |
| 2025-05-23 | -1.82 |
| 2025-05-22 | -1.88 |
| 2025-05-21 | -1.91 |
| 2025-05-20 | -1.89 |
| 2025-05-19 | -1.91 |
| 2025-05-16 | -1.94 |
| 2025-05-15 | -1.89 |
| 2025-05-14 | -1.94 |
| 2025-05-13 | -1.98 |
| 2025-05-12 | -2.03 |
| 2025-05-09 | -2.22 |
| 2025-05-08 | -2.25 |
| 2025-05-07 | -2.15 |
| 2025-05-06 | -2.26 |
| 2025-05-05 | -2.27 |
| 2025-05-02 | -2.34 |
| 2025-04-30 | -2.33 |
| 2025-04-29 | -2.25 |
| 2025-04-28 | -2.23 |
| 2025-04-25 | -2.19 |
| 2025-04-24 | -2.20 |